Nefense, a company specializing in advanced clinical hygiene and airway health, has announced the official launch of its Hypochlorous Acid (HOCl) nasal spray line, expanding its product portfolio with age-specific formulations for adults, children, and infants. The move marks a significant step in addressing respiratory hygiene needs across different age groups, offering a non-pharmaceutical approach to nasal care.
The flagship product, Hyponasal spray, is described as a gentle, clinical-grade biocleanse that flushes irritants, provides soothing relief, and supports natural respiratory defenses without harsh chemicals or steroids. According to the company, the formulations leverage hypochlorous acid, a substance naturally produced by the immune system, to deliver broad-spectrum antimicrobial and anti-inflammatory action. This mechanism helps neutralize bacteria and viruses, potentially preventing upper respiratory infections and combating seasonal allergies.
The launch comes at a time when public interest in non-pharmaceutical hygiene solutions remains high. By tailoring the product to different age groups, Nefense aims to address specific needs: adults may benefit from daily airway maintenance, children from safe allergy relief, and infants from gentle cleansing. The company notes that many clinics and practices nationwide already offer Nefense products, including the xylitol-based XyloClean spray, indicating a growing acceptance of such hygiene measures in clinical settings.
Nefense emphasizes that its products are developed in collaboration with doctors and ENT specialists, bridging the gap between daily hygiene and overall wellness. The company's mission focuses on helping people breathe better and live healthier through science-driven solutions. For more information, the full announcement is available at Newsworthy.ai and distributed by Reportable, Inc.
The implications of this launch are noteworthy: it introduces a steroid-free, chemical-free option for nasal hygiene that may reduce reliance on pharmaceutical interventions for mild respiratory issues. If widely adopted, it could shift preventive care practices, particularly for families seeking safe alternatives for children and infants. Additionally, the age-specific approach acknowledges that respiratory needs vary by age, potentially improving compliance and outcomes.
